drugset / Trial / NCT03641209

Extremely Low Gestatonal Age Infants' Paracetamol Study

NCT03641209

Phase 1/2 Completed 40 enrolled Outi Aikio
RandomizedParallel-groupTriple-blindPrevention

Summary

In the present trial, early, intravenous paracetamol is compared to placebo in extremely premature or low birth weight infants in order to evaluate the effect on ductal closure.

Timeline

Start
2018-09-03
Primary completion
2023-11-03
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 7.5 mg/kg Intravenous

Indications

No indication recorded.